The Maiden Pharmaceuticals Contaminated Cough Syrup Deaths
An Indian-made cough syrup exported to The Gambia was contaminated with industrial solvents used in antifreeze. Dozens of children died of acute kidney injury. Four years on, no one has been convicted in India and a bribery allegation over the domestic lab tests remains unresolved.
The Promise
“Cough and cold syrups manufactured for export meet pharmacopoeial purity standards and are manufactured under licence in accordance with India's Drugs and Cosmetics Act.”
— Maiden Pharmaceuticals Limited, a Haryana-based drug manufacturer licensed by India's Central Drugs Standard Control Organisation and Haryana's state drug authority, Licensed manufacturer of Promethazine Oral Solution, Kofexmalin, Makoff and Magrip N Cold syrups, exported to The Gambia · 1 January 2022
Maiden Pharmaceuticals exported four cough and cold syrup products to The Gambia during 2022, where they were administered to children for common colds and coughs.
The Standard
Exported medicines free of toxic contaminants, manufactured and tested to pharmacopoeial standards under India's Drugs and Cosmetics Act before being licensed for sale or export.
India's Drugs and Cosmetics Act, 1940 and associated Good Manufacturing Practice rules; WHO pharmacopoeial standards for diethylene glycol and ethylene glycol content in oral liquid medicines.
In force from 1 January 2022
The Reality
Starting in July 2022, Gambian hospitals recorded a sharp rise in children presenting with acute kidney injury; by the time the WHO issued a global medical product alert on 5 October 2022, dozens of deaths had been recorded. Independent laboratory testing commissioned by the WHO, and separately a joint investigation by the US Centers for Disease Control and Prevention and Gambian scientists, confirmed the four Maiden Pharmaceuticals syrups were contaminated with the toxic industrial solvents diethylene glycol and ethylene glycol, concluding they had almost certainly caused the deaths of at least 66 children from acute kidney injury. India's central and Haryana state drug regulators halted production at Maiden's Sonipat facility and later found the company had used industrial-grade (rather than pharmaceutical-grade) propylene glycol sourced from an unauthorised supplier. In April 2023, allegations surfaced in India that a Haryana health department official had accepted a bribe to alter test results on samples of the syrups before they were examined in a state laboratory; this allegation remained under investigation as of the most recent reporting reviewed. No criminal conviction of Maiden Pharmaceuticals or its executives had been reported as of the most recent sources available.
As of 1 April 2023
The Gap
Bars share a single zero-based scale. No axis truncation is used to exaggerate or minimize the gap between the two figures.
Timeline
- AnnouncementChild deaths begin rising in The Gambia
Gambian hospitals began recording an unusual cluster of acute kidney injury deaths among young children.
- StatusWHO issues global medical product alert
The WHO named the four Maiden Pharmaceuticals syrups and asked regulators worldwide to remove them from circulation, citing unacceptable levels of diethylene glycol and ethylene glycol.
- StatusIndia halts production at Maiden's Sonipat plant
The Haryana state drug controller suspended Maiden Pharmaceuticals' manufacturing licence pending investigation.
- MilestoneUS CDC-led investigation confirms causal link
A joint US CDC and Gambian scientific investigation concluded contaminated Indian-made syrups almost certainly caused at least 66 child deaths from acute kidney injury.
- StatusBribery allegation over Haryana lab tests surfaces
Reports alleged a Haryana health department official had taken a bribe to alter test results on syrup samples before state laboratory examination.
Legal Status
India's drug regulators suspended Maiden Pharmaceuticals' manufacturing licence and multiple investigations (Indian and international) confirmed the toxic contamination and its causal link to child deaths, but no criminal conviction of the company or its executives is documented in sources reviewed, and a bribery allegation involving Haryana officials remains unresolved.
Manufacturing licence suspended by Haryana authorities in October 2022; no criminal conviction documented in sources reviewed.
Verdict
That the syrups were toxic and caused child deaths in The Gambia is confirmed by independent WHO- and CDC-led scientific investigations, not merely alleged. What remains unresolved is criminal accountability in India: no conviction of the manufacturer or its executives has been reported, and an allegation that Haryana officials were bribed to alter test results has not been publicly concluded.
The scientific finding of contamination and its causal link to deaths is corroborated by multiple independent bodies (WHO, US CDC, Gambian investigators) using separate laboratory testing, leaving little room for dispute on the core facts; the accountability outcome in India, however, is genuinely unresolved in the public record reviewed.
What remains incomplete
- The final outcome of any Indian criminal investigation or prosecution of Maiden Pharmaceuticals or its executives was not established in sources reviewed as of the time of writing.
- The outcome of the alleged bribery of a Haryana health department official over altered lab test results was not confirmed in sources reviewed.
- The exact final death toll varies slightly across sources (commonly cited as 66 to 70); this entry uses the CDC-led investigation's figure without treating a single number as beyond dispute.
Sources
Related investigations
The NEET-UG 2024 Paper Leak Case
India's medical entrance exam for 2.4 million aspirants was compromised by a leak traced to a stolen question-paper trunk in Hazaribagh, Jharkhand. The CBI has filed multiple chargesheets, but the Supreme Court refused to order a national retest.
The Uttar Pradesh Food Grain (PDS) Scam
Between roughly 2002 and 2010, food grain meant for Uttar Pradesh's poor under the Public Distribution System, Antyodaya, Annapurna and Mid-Day Meal schemes was allegedly diverted in bulk to the open market and smuggled across the border, with CBI estimates of the diversion running to tens of thousands of crores of rupees. More than a decade on, hundreds of officials were named in FIRs but this entry could not confirm any major convictions, and UP has continued to top national rankings for PDS grain leakage.
The RG Kar Medical College Case: A Hospital's Duty of Care, Broken
A trainee doctor was raped and murdered inside her own hospital's seminar room in Kolkata in August 2024 -- a place meant to be safe under the hospital administration's basic duty of care to staff on duty. What followed was not just a brutal crime but an alleged cover-up by the hospital's own leadership, a CBI takeover, and nationwide doctors' protests demanding workplace safety that the system had failed to guarantee.